BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20496805)

  • 1. [Clinical and laboratory evaluation of efficiency of Helicobacter pylori eradication].
    Drygina LB; Poiarkova NA; Sablin OA
    Eksp Klin Gastroenterol; 2010; (2):27-31. PubMed ID: 20496805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy.
    Veijola L; Oksanen A; Linnala A; Sipponen P; Rautelin H
    Helicobacter; 2007 Dec; 12(6):605-8. PubMed ID: 18001400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
    Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G
    Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation about usefulness of serum antibody of Helicobacter pylori and serum pepsinogen I/II ratio as a marker of the judgment after eradication therapy].
    Fujisawa T; Kumagai T; Goto A; Fujimori K; Akamatsu T; Kiyosawa K
    Nihon Rinsho; 1999 Jan; 57(1):101-6. PubMed ID: 10036944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study.
    Di Mario F; Moussa AM; Dal Bò N; Caruana P; Pilotto A; Cavallaro LG; Cavestro GM; Iori V; Merli R; Franzé A; Rugge M
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M; Valle J; Härkönen M; Maaroos HI; Peetsalu A
    Hepatogastroenterology; 2005; 52(63):785-91. PubMed ID: 15966205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
    Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
    Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children.
    Guariso G; Basso D; Bortoluzzi CF; Meneghel A; Schiavon S; Fogar P; Farina M; Navaglia F; Greco E; Mescoli C; Zambon CF; Plebani M
    Clin Chim Acta; 2009 Apr; 402(1-2):54-60. PubMed ID: 19135434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes.
    Chang YW; Oh HC; Jang JY; Hwangbo Y; Lee JW; Lee HJ; Joo KR; Dong SH; Kim SS; Kim HJ; Kim BH; Chang R
    Scand J Gastroenterol; 2008; 43(10):1184-93. PubMed ID: 18609140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
    J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.